Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new ‘‘class effect’ ’ para-doxical phenomenon. Two case reports and literature review. Semin Arthritis Rheum. Advance Access publishe
Adalimumab is a full human monoclonal antibody that inhibits tumor necrosis factor-alpha (TNF-&alpha...
Adalimumab is a full human monoclonal antibody that inhibits tumor necrosis factor-alpha (TNF-${\alp...
Etanercept is a soluble receptor fusion protein that inhibits tumor necrosis factor-alpha(TNF-&alpha...
Objectives: to report 2 cases of sarcoidosis developed during treatment with anti-TNFalfa antagonist...
Drug-induced sarcoidosis-like disease is a rare side effect of anti-tumor necrosis factor (anti-TNF)...
International audienceAnti-TNF-alpha agents have been tried in cases of refractory sarcoidosis, givi...
AbstractSarcoidosis is a multisystem granulomatous inflammatory disease of unknown etiology. There i...
Introduction: Infliximab is a chimeric anti-tumor necrosis alpha (TNF-α) monoclonal antibody that in...
Anti-tumor necrosis factor alpha (anti-TNF-a) therapy has been widely used for the management of rhe...
Paradoxical effects or reactions to anti–tumor necrosis factor (anti-TNF) therapy are defined by the...
Anti-tumor necrosis factor alpha (anti-TNF-alpha) therapy has been widely used for the management of...
Sarcoidosis is a systemic chronic granulomatous disease of unknown etiology. It predominantly involv...
Abstract Infliximab is a chimeric monoclonal antibody against tumour necrosis factor (TNF)‐α, with a...
Etanercept is a soluble receptor fusion protein that inhibits tumor necrosis factor-alpha(TNF-&alpha...
The paradoxical adverse effects of tumor necrosis factor-alpha (TNF-alpha) antagonists have been des...
Adalimumab is a full human monoclonal antibody that inhibits tumor necrosis factor-alpha (TNF-&alpha...
Adalimumab is a full human monoclonal antibody that inhibits tumor necrosis factor-alpha (TNF-${\alp...
Etanercept is a soluble receptor fusion protein that inhibits tumor necrosis factor-alpha(TNF-&alpha...
Objectives: to report 2 cases of sarcoidosis developed during treatment with anti-TNFalfa antagonist...
Drug-induced sarcoidosis-like disease is a rare side effect of anti-tumor necrosis factor (anti-TNF)...
International audienceAnti-TNF-alpha agents have been tried in cases of refractory sarcoidosis, givi...
AbstractSarcoidosis is a multisystem granulomatous inflammatory disease of unknown etiology. There i...
Introduction: Infliximab is a chimeric anti-tumor necrosis alpha (TNF-α) monoclonal antibody that in...
Anti-tumor necrosis factor alpha (anti-TNF-a) therapy has been widely used for the management of rhe...
Paradoxical effects or reactions to anti–tumor necrosis factor (anti-TNF) therapy are defined by the...
Anti-tumor necrosis factor alpha (anti-TNF-alpha) therapy has been widely used for the management of...
Sarcoidosis is a systemic chronic granulomatous disease of unknown etiology. It predominantly involv...
Abstract Infliximab is a chimeric monoclonal antibody against tumour necrosis factor (TNF)‐α, with a...
Etanercept is a soluble receptor fusion protein that inhibits tumor necrosis factor-alpha(TNF-&alpha...
The paradoxical adverse effects of tumor necrosis factor-alpha (TNF-alpha) antagonists have been des...
Adalimumab is a full human monoclonal antibody that inhibits tumor necrosis factor-alpha (TNF-&alpha...
Adalimumab is a full human monoclonal antibody that inhibits tumor necrosis factor-alpha (TNF-${\alp...
Etanercept is a soluble receptor fusion protein that inhibits tumor necrosis factor-alpha(TNF-&alpha...